Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence

On 4 September 2024, the Reagan-Udall Foundation for the FDA (FDA Foundation) in collaboration with the Food and Drug Administration (FDA) and the Gates Foundation hosted a workshop titled “Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence”. The event brought...

Full description

Saved in:
Bibliographic Details
Main Authors: Jimi Olaghere, David A. Williams, Jeremy Farrar, Hildegard Büning, Cecelia Calhoun, Tony Ho, Maneesha S. Inamdar, David Liu, Julie Makani, Kwasi Nyarko, Sol Ruiz, John Tisdale, Joseph M. McCune, Esther Boadi, Reagan-Udall Foundation for the FDA
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biomedicines
Subjects:
gene therapy
low-and middle-income countries (LMICs)
sickle cell disease (SCD)
clustered regularly interspaced short palindromic repeats (CRISPR)
chimeric antigen receptor T cell (CAR T cell)
Online Access:https://www.mdpi.com/2227-9059/13/3/758
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/3/758

Similar Items